Erratum to: Prospects for the Use of Marine Sulfated Fucose-Rich Polysaccharides in Treatment and Prevention of COVID-19 and Post-COVID-19 Syndrome

M V Kiselevskiy,N Yu Anisimova,M I Bilan,A I Usov,N E Ustyuzhanina,A A Petkevich,I Zh Shubina,G E Morozevich,N E Nifantiev

DOI: https://doi.org/10.1134/S1068162022340015

Abstract:[This corrects the article DOI: 10.1134/S1068162022060152.].

What problem does this paper attempt to address?

Correction to: Mesenchymal stem cells in the treatment of severe COVID-19

Santosh Kesari,Gregory C Kasper,Lev Verkh,Terese C Hammond,Marla L Matal,Jay W Hammerling,Nikolai Tankovich,Adrianus P Lim,Kevin H Zhao,Tiffany Juarez,Roberta E Redfern,Jaya M Gill,Natsuko Nomura,Audrey Hiemer,Annie Heng,Jessica Shoemaker

DOI: https://doi.org/10.1186/s41231-021-00098-x

Abstract:[This corrects the article DOI: 10.1186/s41231-021-00095-0.].
Erratum to: Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1)

N V Goncharov,K A Vasilyev,I V Kudryavtsev,P P Avdonin,D A Belinskaia,M A Stukova,O V Shamova,P V Avdonin

DOI: https://doi.org/10.1134/S0022093022020284

Abstract:[This corrects the article DOI: 10.1134/S0022093022010203.].
Erratum to: "How Fucose of Blood Group Glycotypes Programs Human Gut Microbiota" [Biochemistry (Moscow), 82, 973 (2017)]

S V Kononova

DOI: https://doi.org/10.1134/S0006297917100157

Abstract:This corrects the article DOI: 10.1134/S0006297917090012.
Erratum to: "Rhamnose-Containing Cell Wall Glycopolymers from Rathayibacter toxicus VKM Ac-1600 and "Rathayibacter tanaceti" VKM Ac-2596" [Biochemistry (Moscow), 83, 717 (2018)]

A S Shashkov,E M Tul'skaya,A S Dmitrenok,G M Streshinskaya,N V Potekhina,S N Senchenkova,N F Piskunkova,L V Dorofeeva,L I Evtushenko

DOI: https://doi.org/10.1134/S0006297918070106

Abstract:This corrects the article DOI: 10.1134/S0006297918060093.
Corrigendum to ‘Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and integrative review’ [Trends in Food Science & Technology 120 (2022) 174–192]

Douglas Xavier-Santos,Marina Padilha,Giovanna Alexandre Fabiano,Gabriel Vinderola,Adriano Gomes Cruz,Katia Sivieri,Adriane Elisabete Costa Antunes

DOI: https://doi.org/10.1016/j.tifs.2022.01.028

2022-03-01

Abstract:[This corrects the article DOI: 10.1016/j.tifs.2021.12.033.].

food science & technology
Erratum to: "Amphipathic CRAC-Containing Peptides Derived from the Influenza Virus A M1 Protein Modulate Cholesterol-Dependent Activity of Cultured IC-21 Macrophages" [Biochemistry (Moscow), 83, 982 (2018)]

A Ya Dunina-Barkovskaya,Kh S Vishnyakova,A O Golovko,A M Arutyunyan,L A Baratova,O V Batishchev,V A Radyukhin

DOI: https://doi.org/10.1134/S0006297918090158

Abstract:This corrects the article DOI: 10.1134/S0006297918080096.
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Correction to "Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2"

Abdul-Rahman Azizogli,Varun Pai,Francesco Coppola,Roya Jafari,Joseph B Dodd-O,Rohan Harish,Bhavani Balasubramanian,Jatin Kashyap,Amanda M Acevedo-Jake,Petr Kral,Vivek A Kumar

DOI: https://doi.org/10.1021/acsomega.4c06853

IF: 4.1

2024-08-16

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.2c06384.].
Erratum: Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review: Erratum

DOI: https://doi.org/10.1097/MS9.0000000000002497

2024-09-04

Abstract:[This corrects the article DOI: 10.1097/MS9.0000000000001601.].
Corrigendum: Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: a systematic review and meta-analysis

Cong-wen Yang,Ru-dong Chen,Qing-run Zhu,Shi-jie Han,Ming-jie Kuang

DOI: https://doi.org/10.3389/fimmu.2023.1344990

IF: 7.3

2024-01-04

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.923286.].

immunology
Erratum: Unmasking a New Type of Gastrointestinal Foreign Body in the COVID-19 Era: Erratum

DOI: https://doi.org/10.1097/PG9.0000000000000362

2023-09-06

Abstract:[This corrects the article DOI: 10.1097/PG9.0000000000000315.].
Corrigendum: Interferon-α2b Treatment for COVID-19

Qiong Zhou,Virginia Chen,Casey P. Shannon,Xiao-Shan Wei,Xuan Xiang,Xu Wang,Zi-Hao Wang,Scott J. Tebbutt,Tobias R. Kollmann,Eleanor N. Fish

DOI: https://doi.org/10.3389/fimmu.2020.615275

IF: 7.3

2020-10-27

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.01061.].

immunology
Erratum: Analysis on the medication rule of traditional Chinese medicine in the treatment of COVID-19 patients: Erratum

DOI: https://doi.org/10.1097/HM9.0000000000000073

Abstract:[This corrects the article DOI: 10.1097/HM9.0000000000000030.].
Corrigendum: the Neuroprotective Effects of Fisetin, a Natural Flavonoid in Neurodegenerative Diseases: Focus on the Role of Oxidative Stress.

Syed Shams Ul Hassan,Saptadip Samanta,Raju Dash,Tomasz M Karpiński,Emran Habibi,Abdul Sadiq,Amirhossein Ahmadi,Simona Gabriela Bungau

DOI: https://doi.org/10.3389/fphar.2024.1431842

IF: 5.6

2024-01-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.1015835.].
Erratum: Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial

Frontiers Production Office

DOI: https://doi.org/10.3389/fmed.2023.1289307

IF: 3.9

2023-09-19

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2023.1139046.].

medicine, general & internal
Corrigendum to "The distinction of area postrema syndrome between MOGAD and NMOSD" [Heliyon 10(10) (May 2024) e30633]

Zhiming Zhou,Ying Chen,Jingzhi Zhangbao,Junfeng Xu,Chao Quan,Lei Zhou

DOI: https://doi.org/10.1016/j.heliyon.2024.e32900

IF: 3.776

2024-06-21

Heliyon

Abstract:[This corrects the article DOI: 10.1016/j.heliyon.2024.e30633.].
Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?

José M. Pérez de la Lastra,Uttpal Anand,Sergio González-Acosta,Manuel R. López,Abhijit Dey,Elza Bontempi,Antonio Morales delaNuez

DOI: https://doi.org/10.3389/fimmu.2024.1365827

IF: 7.3

2024-01-26

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.921483.].

immunology
Correction: Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review

Ariel Izcovich,Martín Alberto Ragusa,Fernando Tortosa,María Andrea Lavena Marzio,Camila Agnoletti,Agustín Bengolea,Agustina Ceirano,Federico Espinosa,Ezequiel Saavedra,Verónica Sanguine,Alfredo Tassara,Candelaria Cid,Hugo Norberto Catalano,Arnav Agarwal,Farid Foroutan,Gabriel Rada

DOI: https://doi.org/10.1371/journal.pone.0269291

IF: 3.7

2022-05-26

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0241955.].

multidisciplinary sciences
Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China

Wei Cao,Xiaosheng Liu,Ke Hong,Zhiyong Ma,Yuelun Zhang,Ling Lin,Yang Han,Yong Xiong,Zhengyin Liu,Lianguo Ruan,Taisheng Li

DOI: https://doi.org/10.3389/fimmu.2021.671443

IF: 7.3

2021-03-22

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.627844/full.].

immunology
Corrigendum: C-reactive protein isoforms as prognostic markers of COVID-19 severity

Blanca Molins,Marc Figueras-Roca,Oliver Valero,Victor Llorens,Sara Romero-Vázquez,Oriol Sibila,Alfredo Adan,Carolina Garcia-Vidal,Alex Soriano

DOI: https://doi.org/10.3389/fimmu.2024.1447976

IF: 7.3

2024-06-22

Frontiers in Immunology

Abstract:This article is a correction to: C-reactive protein isoforms as prognostic markers of COVID-19 severity

immunology

Erratum to: Prospects for the Use of Marine Sulfated Fucose-Rich Polysaccharides in Treatment and Prevention of COVID-19 and Post-COVID-19 Syndrome

Correction to: Mesenchymal stem cells in the treatment of severe COVID-19

Erratum to: Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1)

Erratum to: "How Fucose of Blood Group Glycotypes Programs Human Gut Microbiota" [Biochemistry (Moscow), 82, 973 (2017)]

Erratum to: "Rhamnose-Containing Cell Wall Glycopolymers from Rathayibacter toxicus VKM Ac-1600 and "Rathayibacter tanaceti" VKM Ac-2596" [Biochemistry (Moscow), 83, 717 (2018)]

Corrigendum to ‘Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and integrative review’ [Trends in Food Science & Technology 120 (2022) 174–192]

Erratum to: "Amphipathic CRAC-Containing Peptides Derived from the Influenza Virus A M1 Protein Modulate Cholesterol-Dependent Activity of Cultured IC-21 Macrophages" [Biochemistry (Moscow), 83, 982 (2018)]

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Correction to "Scalable Inhibitors of the Nsp3-Nsp4 Coupling in SARS-CoV-2"

Erratum: Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review: Erratum

Corrigendum: Efficacy of umbilical cord mesenchymal stromal cells for COVID-19: a systematic review and meta-analysis

Erratum: Unmasking a New Type of Gastrointestinal Foreign Body in the COVID-19 Era: Erratum

Corrigendum: Interferon-α2b Treatment for COVID-19

Erratum: Analysis on the medication rule of traditional Chinese medicine in the treatment of COVID-19 patients: Erratum

Corrigendum: the Neuroprotective Effects of Fisetin, a Natural Flavonoid in Neurodegenerative Diseases: Focus on the Role of Oxidative Stress.

Erratum: Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial

Corrigendum to "The distinction of area postrema syndrome between MOGAD and NMOSD" [Heliyon 10(10) (May 2024) e30633]

Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?

Correction: Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review

Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China

Corrigendum: C-reactive protein isoforms as prognostic markers of COVID-19 severity

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]